Skip to content

Clinical trials

Lymphoma, T-Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20091
20101
20131
20161
20171
20192
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center2
Chonbuk National University Hospital1
Chonnam National University Hospital1
Corvus Pharmaceuticals, Inc.1
GC Cell Corporation1
Keimyung University Dongsan Medical Center1
Novartis Pharmaceuticals1
Prelude Therapeutics1
Seagen Inc.1
Singapore General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell12
Lymphoma, Large-Cell, Anaplastic4
Immunoblastic Lymphadenopathy3
Lymphoma3
Lymphoma, Extranodal NK-T-Cell2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Lymphoma, T-Cell, Peripheral2
Recurrence2
Endometrial Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.